Jarvis
  • CATEGORIES
    • Equity Market
    • Investing Basics
    • Interesting Read
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Newsletter
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
  • CATEGORIES
    • Equity Market
    • Investing Basics
    • Interesting Read
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Newsletter
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
No Result
View All Result
Home Newsletter

Tuesday, 9th February 2021

by Sumit Chanda
February 9, 2021
in Newsletter
Reading Time: 4 mins read
A A
0
Share on FacebookShare on Twitter

Bharat Petroleum Q3 PAT was down -11.9% at Rs.1,565 crore largely on the back of exceptional losses. The top-line was flat with 1.59% growth in the Dec-20 quarter at Rs.87,293 crore. For the 9-month period to Dec-20, the gross refining margins or GRM fell from $3.15/bbl to $2.90/bbl with HSD Retail and ATF coming under pressure. Sound inventory management helped OPM expanded from 2.39% to 5.02% in Dec-20 quarter. PAT tapered as BPCL took a hit of Rs.419 crore on account of ESOP expensing and another Rs.730 crore due to asset impairment provisions for its subsidiary Bharat Petro Resources. 

In a significant boost for the Future-RRVL deal, the Delhi High Court overturned an order stalling the $3.4 billion deal to sell the retail assets of Future group to Reliance Retail. Amazon had challenged the sale as it depleted the value of their investment in Future Coupons. Last week, the court sided with Amazon and put Future’s RRVL deal on hold. Future group had appealed against this order saying that its creditors would be at significant risk if the deal failed. While neither company has made a public statement due to the matter being sub-judice, it is certainly a setback for Amazon. While Amazon has made allegations against the Future group and its promoters, Kishor Biyani has consistently denied such allegations. One view in the market is also that Amazon may be just trying to push the deal to a corner.

Torrent Pharma reported an 18.33% spike in net profit to Rs.297 crore on the strength of cost controls. Top line was almost flat with just 1.48% growth in revenues for the Dec-20 quarter. While the overall revenues of Torrent may have been flat, the India revenues grew by 7% at Rs.930 crore, which led the market recovery. India also saw momentum in chronic brands and sub-chronic brands. The US revenues for the quarter were sharply down 24% on a yoy basis. Brazil revenues also contracted but German revenues grew by 21%, among Torrent’s major markets. It was a case of cost optimization working. 

India has challenged the international arbitration tribunal’s verdict on Vodafone in a Singapore High Court. The tribunal had overturned India’s demand for Rs.22,100 crore in retrospective taxes from Vodafone. The government is yet to crystallize its response to the Cairn order by the Singapore arbitration tribunal, which is along similar lines. These demands pertain to the 2007 acquisition of Hutch India by Vodafone PLC from Hutchison Whampoa based out of Hong Kong. In both cases, the Tribunal had given an order against India as the Indo-UK treaty makes it mandatory to offer this concession.

Securitisation volumes may have taken a hit during the pandemic but has sharply risen in the Dec-20 quarter. The shadow banking or NBFC sector securitised Rs.24,400 crore of retail loan assets; a yoy growth of 61%. What is more interesting is that the NBFC securitization value has been consistently growing every sequential quarter. The number of originators undertaking securitization has shown signs of improvement. In Dec-20 quarter 50 originators were active in securitization while it was 45 and 18 in Q2 and Q1. ICRA has projected annual securitisation volumes of Rs.90,000 crore in FY21.

President Vladimir Putin may have reasons to celebrate as Russia’s COVID vaccine, Sputnik V, is suddenly garnering a lot of interest globally. Already, the companies across the world are lining up for supplies of Sputnik V. Recent tests have evidenced that the Sputnik V protects against the Coronavirus as well as the US and European shots. Also, the Russian vaccine is noted to be a lot more effective than the Chinese vaccine candidate. As of now, over 20 countries approved the vaccine for use and this includes Hungary from the EU as well as other countries like Brazil and India on the threshold of approval. In fact, the results the late-stage trials of 20,000 participants showed that the vaccine had 91.6% success rate. Ironically, the domestic demand for the vaccine remained weak as the local public remains suspicious.

Sumit Chanda

Sumit Chanda

Sumit has 18 years of experience in BFSI industry, into devising strategy for various functions, Investments and Managing Asset Portfolios. Specializes in Strategy & implementation in sales & operations, Team management, IT implementation, Affiliations.

Related Posts

Illustration of bullish and bearish market trends with digital bull and bear icons standing on stacked gold coins, promoting 6 multibagger stocks that surged in 2025. "Is your portfolio still in 2022?" – Jarvis AI

These 6 Multibagger Stocks Exploded in 2025 — Is Your Portfolio Still in 2022?

by Sumit Chanda
June 26, 2025
0
5.3k

In 2025, six multibagger stocks delivered explosive returns—while many investors were still stuck with outdated portfolios. Are you missing the...

Jarvis Invest blog - ‘Liquidity or Inflation? RBI Policy June 2025’ reflecting monetary policy focus

Liquidity or Inflation? RBI Policy June 2025

by Sumit Chanda
June 6, 2025
0
9

On June 6, 2025, the Reserve Bank of India took a bold step to revive economic momentum by slashing both...

Gold vs Stocks: Where should indians invest for better returns?

Gold vs Stocks: Where should Indians invest for better returns?

by Sumit Chanda
May 30, 2025
0
5.3k

As the world’s investment landscape shifts, investors often face the dilemma of where to park their funds for optimal returns....

NRI Investment Plan in India

How can NRIs invest Rs 50 lakh in India?

by Sumit Chanda
May 23, 2025
0
5.3k

When it comes to investment in India, Non-resident Indians (NRIs) are always skeptical about where to invest their hard-earned money....

Top 5 best growth stocks in India and sectors to watch in 2025

Top 5 Best Growth Stocks in India & Sectors to Watch in 2025

by Sumit Chanda
May 8, 2025
0
5.4k

You see the market correction in late 2024 and early 2025 was driven by weak economic data, corporate earnings misses,...

Best sectors to invest in 2025

India’s Fastest-Growing & Best sectors to invest in 2025

by Sumit Chanda
April 29, 2025
0
5.6k

In this blog, we are going to delve into the best sectors to invest in 2025 anticipated to experience the...

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Equity Market
  • Investing Basics
  • AI for investing
  • Trending Stock Market News: Quick Reads
  • Interesting Read
  • Financial Planning
  • Portfolio Management
  • Newsletter
Connect with us: customersupport@jarvisinvest.com

© 2023 Jarvis Invest

No Result
View All Result
  • CATEGORIES
    • Equity Market
    • Investing Basics
    • Interesting Read
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Newsletter
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner

© 2023 Jarvis Invest

Go to mobile version